Breaking News Instant updates and real-time market news.

ALNY

Alnylam

$79.73

1.36 (1.74%)

05:23
12/07/18
12/07
05:23
12/07/18
05:23

Piper remains buyers of Alnylam following recent weakness

Alnylam Pharmaceuticals' R&D day highlighted the the transition into a commercial stage company with multiple late stage programs, Piper Jaffray analyst Edward Tenthoff tells investors in a research note. Alnylam is expanding RNAi drug discovery outside of the liver into central nervous system and cardiovascular disease, adds the analyst. He says Piper remains buyers of Alnylam on recent weakness ahead of new RNAi drug approvals and data read-outs. Tenthoff reiterates an Overweight rating on the stock with a $160 price target.

ALNY Alnylam
$79.73

1.36 (1.74%)

11/07/18
PIPR
11/07/18
NO CHANGE
Target $160
PIPR
Overweight
Alnylam weakness a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff remains a buyer of Alnylam Pharmaceuticals on weakness after the company reported initial Onpattro Q3 sales of $460,000, below his $3M estimate. The initial launch metrics and advantageous commercial profile versus Tegsedi should translate into adoption, Tenthoff tells investors in a research note. 125 patient start forms submitted as of Q3, which is not the only source of demand, could translate into $11M in further Onpattro sales over the next few quarters, says the analyst. He reiterates an Overweight rating on Alnylam shares with a $160 price target.
11/15/18
STFL
11/15/18
NO CHANGE
Target $111
STFL
Buy
Alnylam management 'exudes confidence' in TTR launch, says Stifel
After hosting a dinner with Alnylam CEO John Maraganore and the company's management, Stifel analyst Paul Matteis said management "exudes confidence" that Onpattro can penetrate a substantial portion of the diagnosed haTTR population while acknowledging that it takes a little time to convert "start forms" into paying commercial patients. Management also seems "completely at ease" ahead of the full readout of the givosiran phase 3 ENVISION data, said Matteis, who keeps a Buy rating and $111 price target on Alnylam shares.
11/27/18
LEER
11/27/18
INITIATION
Target $63
LEER
Market Perform
Alnylam initiated with a Market Perform at Leerink
Leerink analyst Mani Foroohar initiated Alnylam with a Market Perform rating and a price target of $63.
11/27/18
LEER
11/27/18
INITIATION
LEER
Leerink initiates select Genetic Medicine names on increasing regulatory clarity
Leerink analyst Mani Foroohar initiated select Genetic Medicine stocks, stating that the field is "is rich with companies developing drugs" to treat rare diseases and that he is increasingly more bullish on "innovation velocity and increasing regulatory clarity in the sector. Based on his "balanced view of pricing dynamics", the analyst issues an Outperform rating on Wave Life Sciences (WVE), Rocket Pharmaceuticals (RCKT), Intellia Therapeutics (NTLA), Eidos Therapeutics (EIDX), Dicerna (DRNA) and Bluebird Bio (BLUE). The analyst likes Wave Life Sciences as a pure play on Oligotherapeutics and its stereopure chemistry platform as a differentiated approach to oligo drug design. Foroohar is positive on Rocket Pharma's lead assets in gene therapies for Fanconi Anemia and Leukocyte Adhesion Deficiency-I "which will likely be the company's first potential approved product." The analyst is positive on Intellia Therapeutics' "robust balance sheet to support development, trading at a material discount to closest comps peers". For Eidos, the analyst cites the prospects of its drug candidate for TTR amyloidosis currently in a placebo-controlled Phase 2 study that may offer a competitive profile relative to Pfizer's (PFE) tafamidis. For Dicerna, Foroohar notes that its DCR-PHXC "is an RNAi therapeutic that targets lactate dehydrogenase A for the treatment of all subtypes of Primary Hyperoxaluria vs. competitor Alnylam's (ALNY) lumasiran, which only treats PH Type 1. For Bluebird Bio, the analyst is positive on its position as a "leader in ex vivo gene therapy, with four programs with visibility towards near-term regulatory approval". Foroohar initiates Avrobio (AVRO), Alnylam (ALNY), and Ionis Pharmaceuticals (IONS) with Market Perform rating based on competitive launches for their products along with "mixed" early signs of their results. The analyst also rates Regenxbio (RGNX) at underperform, saying that its "current valuation more than accounts for robust royalty streams from sales in spinal muscular atrophy" and other partnered assets.

TODAY'S FREE FLY STORIES

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

, SPX

S&P 500

$0.00

(0.00%)

19:57
12/11/18
12/11
19:57
12/11/18
19:57
Periodicals
Trump: Fed would be 'foolish' to raise rates next week, Reuters says »

In an interview with…

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

, SPX

S&P 500

$0.00

(0.00%)

19:48
12/11/18
12/11
19:48
12/11/18
19:48
Periodicals
Trump may intervene in Huawei CFO arrest to get China trade deal, Reuters says »

In an interview with…

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TME

Tencent Music

$0.00

(0.00%)

19:33
12/11/18
12/11
19:33
12/11/18
19:33
Syndicate
Tencent Music 82M share IPO priced at $13.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

TME

Tencent Music

$0.00

(0.00%)

19:26
12/11/18
12/11
19:26
12/11/18
19:26
Syndicate
Breaking Syndicate news story on Tencent Music »

Tencent Music prices IPO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

CRM

Salesforce

$136.83

-0.46 (-0.34%)

19:25
12/11/18
12/11
19:25
12/11/18
19:25
Conference/Events
Salesforce management to meet with Goldman Sachs »

Alex Dayon, President and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 19

    Dec

  • 20

    Dec

  • 03

    Mar

O

Realty Income

$66.30

0.58 (0.88%)

19:06
12/11/18
12/11
19:06
12/11/18
19:06
Hot Stocks
Realty Income raises monthly dividend to 22.1c per share from 22.05c »

Realty Income Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKH

Black Hills

$67.28

0.06 (0.09%)

19:02
12/11/18
12/11
19:02
12/11/18
19:02
Hot Stocks
Black Hills buys 50% interest in Busch Ranch I Wind Farm »

Black Hills Corp.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXNX

Axonics

$15.66

-0.36 (-2.25%)

, PVTL

Pivotal Software

$17.80

-0.23 (-1.28%)

18:59
12/11/18
12/11
18:59
12/11/18
18:59
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS:…

AXNX

Axonics

$15.66

-0.36 (-2.25%)

PVTL

Pivotal Software

$17.80

-0.23 (-1.28%)

HAIN

Hain Celestial

$18.80

-0.38 (-1.98%)

URI

United Rentals

$101.89

0.02 (0.02%)

VKTX

Viking Therapeutics

$9.47

0.01 (0.11%)

FSLR

First Solar

$42.43

-0.79 (-1.83%)

JAZZ

Jazz Pharmaceuticals

$140.46

0.9 (0.64%)

SEIC

SEI Investments

$48.50

-0.64 (-1.30%)

BEN

Franklin Resources

$31.53

-0.52 (-1.62%)

PLAY

Dave & Buster's

$51.08

-1.44 (-2.74%)

AEO

American Eagle

$19.03

-0.49 (-2.51%)

ARWR

Arrowhead

$13.61

-0.05 (-0.37%)

MRNS

Marinus Pharmaceuticals

$5.10

-0.14 (-2.67%)

FLDM

Fluidigm

$7.58

-0.11 (-1.43%)

TOCA

Tocagen

$12.85

0.2 (1.58%)

LAND

Gladstone Land

$13.33

-0.16 (-1.19%)

ANGI

Angi Homeservices

$16.62

-0.11 (-0.66%)

BAC

Bank of America

$24.58

-0.17 (-0.69%)

MS

Morgan Stanley

$40.62

-0.07 (-0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 11

    Dec

  • 13

    Dec

  • 13

    Dec

  • 14

    Dec

  • 14

    Dec

  • 19

    Dec

  • 20

    Dec

  • 20

    Dec

  • 12

    Feb

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 13

    Dec

  • 13

    Dec

EW

Edwards Lifesciences

$163.20

1.2 (0.74%)

, BSX

Boston Scientific

$36.55

0.41 (1.13%)

18:47
12/11/18
12/11
18:47
12/11/18
18:47
Hot Stocks
Edwards says does not expect to pay $35M award in Boston Scientific case »

Edwards Lifesciences (EW)…

EW

Edwards Lifesciences

$163.20

1.2 (0.74%)

BSX

Boston Scientific

$36.55

0.41 (1.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

RARX

RA Pharmaceuticals

$15.97

-1.61 (-9.16%)

18:41
12/11/18
12/11
18:41
12/11/18
18:41
Syndicate
RA Pharmaceuticals 8.4M share Secondary priced at $15.50 »

Jefferies, BMO Capital,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

HTLF

Heartland Financial

$49.30

-0.24 (-0.48%)

18:38
12/11/18
12/11
18:38
12/11/18
18:38
Hot Stocks
Heartland Financial announces special cash dividend of 5c »

Heartland Financial USA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANGI

Angi Homeservices

$16.62

-0.11 (-0.66%)

18:24
12/11/18
12/11
18:24
12/11/18
18:24
Syndicate
Angi Homeservices 1.5M share Spot Secondary priced at $16.40 »

The deal priced within…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

, SPX

S&P 500

$0.00

(0.00%)

18:24
12/11/18
12/11
18:24
12/11/18
18:24
Periodicals
Huawei CFO Meng granted bail by Canadian judge, Bloomberg reports »

Huawei Technologies Co.…

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$36.55

0.41 (1.13%)

, EW

Edwards Lifesciences

$163.20

1.2 (0.74%)

18:14
12/11/18
12/11
18:14
12/11/18
18:14
Hot Stocks
Boston Scientific says it 'prevails' in U.S. Edwards Lifesciences litigation »

Boston Scientific (BSX)…

BSX

Boston Scientific

$36.55

0.41 (1.13%)

EW

Edwards Lifesciences

$163.20

1.2 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

MSFT

Microsoft

$108.67

1.11 (1.03%)

18:14
12/11/18
12/11
18:14
12/11/18
18:14
Hot Stocks
Microsoft CMO Chris Capossela sells 4K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

GLD

SPDR Gold Shares

$117.55

-0.13 (-0.11%)

18:05
12/11/18
12/11
18:05
12/11/18
18:05
Hot Stocks
SPDR Gold Shares holdings rise to 763.56MT from 760.32MT »

This is the third…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

, SPX

S&P 500

$0.00

(0.00%)

18:04
12/11/18
12/11
18:04
12/11/18
18:04
Periodicals
Breaking Periodicals news story on SPDR S&P 500 ETF Trust, S&P 500 »

Huawei CFO Meng granted…

SPY

SPDR S&P 500 ETF Trust

$264.13

0.04 (0.02%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIEGY

Siemens

$0.00

(0.00%)

17:56
12/11/18
12/11
17:56
12/11/18
17:56
Periodicals
Siemens to close Texas turbines facility, dismiss 200 workers, Reuters says »

Siemens intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CABO

Cable One

$871.98

9.68 (1.12%)

17:56
12/11/18
12/11
17:56
12/11/18
17:56
Hot Stocks
Cable One to rebrand as Sparklight in the summer of 2019 »

Cable One announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AJRD

Aerojet Rocketdyne

$35.40

0.02 (0.06%)

17:53
12/11/18
12/11
17:53
12/11/18
17:53
Hot Stocks
Aerojet Rocketdyne awarded DARPA contract to design OpFires propulsion system »

Aerojet Rocketdyne said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGNC

AGNC Investment

$17.92

0.045 (0.25%)

17:45
12/11/18
12/11
17:45
12/11/18
17:45
Hot Stocks
AGNC Investment reports tangible net book value of $16.76 per share »

AGNC Investment …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TM

Toyota

$120.40

-0.47 (-0.39%)

, PCRFY

Panasonic

$0.00

(0.00%)

17:40
12/11/18
12/11
17:40
12/11/18
17:40
Periodicals
Breaking Periodicals news story on Toyota, Panasonic »

Panasonic to supply…

TM

Toyota

$120.40

-0.47 (-0.39%)

PCRFY

Panasonic

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDAQ

Nasdaq

$87.28

0.08 (0.09%)

17:37
12/11/18
12/11
17:37
12/11/18
17:37
Hot Stocks
Nasdaq acquires Quandl to 'advance' the use of alternative data »

Nasdaq announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KL

Kirkland Lake Gold

$24.36

0.58 (2.44%)

17:36
12/11/18
12/11
17:36
12/11/18
17:36
Hot Stocks
Kirkland Lake Gold raises dividend to C$0.04 from C$0.03 »

Kirkland Lake Gold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$36.55

0.41 (1.13%)

, EW

Edwards Lifesciences

$163.20

1.2 (0.74%)

17:26
12/11/18
12/11
17:26
12/11/18
17:26
Periodicals
Breaking Periodicals news story on Boston Scientific, Edwards Lifesciences »

Boston Scientific wins…

BSX

Boston Scientific

$36.55

0.41 (1.13%)

EW

Edwards Lifesciences

$163.20

1.2 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.